Live feed

Peptide news, worldwide.

A live, positive-sentiment feed of peptide research, metabolic science and regenerative medicine — curated hourly from global sources.

New this week

Fresh stories

Archive

Past articles

Older positive-sentiment coverage we've saved from the feed.

Manufacturing Chemist24 Jul 2026

Eli Lilly’s retatrutide hits Phase III goals with FDA filing planned for 2027 - Manufacturing Chemist

Eli Lilly’s retatrutide hits Phase III goals with FDA filing planned for 2027 Manufacturing Chemist

Read source
News-Medical24 Jul 2026

Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits - News-Medical

Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits News-Medical

Read source
FoodProcessing.com.au23 Jul 2026

Frog peptide could increase the shelf life of strawberries - FoodProcessing.com.au

Frog peptide could increase the shelf life of strawberries FoodProcessing.com.au

Read source
BioPharma Dive23 Jul 2026

Lilly, with new data, to seek FDA approval of obesity drug retatrutide - BioPharma Dive

Lilly, with new data, to seek FDA approval of obesity drug retatrutide BioPharma Dive

Read source
Fierce Biotech23 Jul 2026

Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clear - Fierce Biotech

Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clear Fierce Biotech

Read source
EMJ23 Jul 2026

GLP-1 Use Linked to Breast Cancer Survival in Patients with Diabetes - EMJ

GLP-1 Use Linked to Breast Cancer Survival in Patients with Diabetes EMJ

Read source
NPR23 Jul 2026

FDA panel supports broadening access to peptides popular on the gray market - NPR

FDA panel supports broadening access to peptides popular on the gray market NPR

Read source
Nursing Times22 Jul 2026

Weight loss drugs show promise for treating alcohol addiction - Nursing Times

Weight loss drugs show promise for treating alcohol addiction Nursing Times

Read source
The Independent22 Jul 2026

New study links weight loss jabs to huge drop in alcohol-related hospital admissions - The Independent

New study links weight loss jabs to huge drop in alcohol-related hospital admissions The Independent

Read source
Well Nation22 Jul 2026

PwC study: a quarter of GLP-1 users increase their fitness spend - Well Nation

PwC study: a quarter of GLP-1 users increase their fitness spend Well Nation

Read source
News-Medical22 Jul 2026

Newer GLP-1 medications may reduce alcohol-related hospitalization risk - News-Medical

Newer GLP-1 medications may reduce alcohol-related hospitalization risk News-Medical

Read source
CBS News21 Jul 2026

GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds - CBS News

GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds CBS News

Read source
Harvard University20 Jul 2026

Women more likely to marry, land jobs after taking GLP-1s - Harvard University

Women more likely to marry, land jobs after taking GLP-1s Harvard University

Read source
Medium17 Jul 2026

The Most Promising Peptide You’ve Probably Never Heard Of: Why ARA 290 Could Revolutionize Nerve… - Medium

The Most Promising Peptide You’ve Probably Never Heard Of: Why ARA 290 Could Revolutionize Nerve… Medium

Read source
Neuroscience News16 Jul 2026

GLP-1’s Reduce Binge Eating Symptoms - Neuroscience News

GLP-1’s Reduce Binge Eating Symptoms Neuroscience News

Read source
Medical Xpress16 Jul 2026

Study identifies patients with obesity most likely to benefit from GLP-1-based treatment - Medical Xpress

Study identifies patients with obesity most likely to benefit from GLP-1-based treatment Medical Xpress

Read source
Phys.org16 Jul 2026

Natural peptide switches from calmodulin to the cancer-associated protein midkine depending on the ion environment - Phys.org

Natural peptide switches from calmodulin to the cancer-associated protein midkine depending on the ion environment Phys.org

Read source
Mayo Clinic News Network16 Jul 2026

Study identifies patients with obesity most likely to benefit from GLP-1-based treatment - Mayo Clinic News Network

Study identifies patients with obesity most likely to benefit from GLP-1-based treatment Mayo Clinic News Network

Read source
Health and Me16 Jul 2026

GLP-1 Weight-Loss Drugs Show Promise for 17 Million With Binge Eating Disorder, Suggests Study - Health and Me

GLP-1 Weight-Loss Drugs Show Promise for 17 Million With Binge Eating Disorder, Suggests Study Health and Me

Read source
News-Medical16 Jul 2026

Weight loss drugs may reduce binge eating disorder symptoms - News-Medical

Weight loss drugs may reduce binge eating disorder symptoms News-Medical

Read source
HCP Live15 Jul 2026

REMAIN-1: Improved GLP-1-Induced Weight Loss Retention With Revita DMR System - HCP Live

REMAIN-1: Improved GLP-1-Induced Weight Loss Retention With Revita DMR System HCP Live

Read source
News-Medical15 Jul 2026

GLP-1 receptor activation linked to lower depression and bipolar disorder odds - News-Medical

GLP-1 receptor activation linked to lower depression and bipolar disorder odds News-Medical

Read source
Harvard Health15 Jul 2026

GLP-1 weight-loss drugs may lower the need for knee replacement - Harvard Health

GLP-1 weight-loss drugs may lower the need for knee replacement Harvard Health

Read source
Whoopsee15 Jul 2026

Dr. Nirusha Kumaran Discusses the Future of Peptides: Regenerative Medicine, Longevity, and New Frontiers - Whoopsee

Dr. Nirusha Kumaran Discusses the Future of Peptides: Regenerative Medicine, Longevity, and New Frontiers Whoopsee

Read source
ScienceDaily14 Jul 2026

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging - ScienceDaily

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging ScienceDaily

Read source
Yahoo Health13 Jul 2026

GLP-1s Grow Up: What the Latest Research Means for People Taking Them - Yahoo Health

GLP-1s Grow Up: What the Latest Research Means for People Taking Them Yahoo Health

Read source
CMAJ | Journal13 Jul 2026

Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysis - CMAJ | Journal

Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysis CMAJ | Journal

Read source
Yahoo Finance Singapore12 Jul 2026

Understanding Peptide Supplements: PureHealth Research Highlights Morikol® Tripeptides for Joint, Skin, and Hair Wellness - Yahoo Finance Singapore

Understanding Peptide Supplements: PureHealth Research Highlights Morikol® Tripeptides for Joint, Skin, and Hair Wellness Yahoo Finance Singapore

Read source
American Society for Microbiology9 Jul 2026

GLP-1 Agonists May Help People With Diabetes and Long COVID - American Society for Microbiology

GLP-1 Agonists May Help People With Diabetes and Long COVID American Society for Microbiology

Read source
Verywell Health9 Jul 2026

New Research Shows GLP-1 Drugs May Help Reduce Blood Pressure - Verywell Health

New Research Shows GLP-1 Drugs May Help Reduce Blood Pressure Verywell Health

Read source
University of Rochester8 Jul 2026

Could GLP-1 Medications Help Lower Cancer Risk? What New Research Suggests - University of Rochester

Could GLP-1 Medications Help Lower Cancer Risk? What New Research Suggests University of Rochester

Read source
BioXconomy7 Jul 2026

Breakthrough peptide repairs nerves after spinal cord injury in clinical trial - BioXconomy

Breakthrough peptide repairs nerves after spinal cord injury in clinical trial BioXconomy

Read source
Nature3 Jul 2026

The impact of glucagon-like peptide-1 receptor agonists on objective physical activity in adults: a systematic review and exploratory meta-analysis - Nature

The impact of glucagon-like peptide-1 receptor agonists on objective physical activity in adults: a systematic review and exploratory meta-analysis Nature

Read source
Healthline3 Jul 2026

New Biweekly GLP-1 Shot Lowers Blood Sugar, Supports Weight Loss - Healthline

New Biweekly GLP-1 Shot Lowers Blood Sugar, Supports Weight Loss Healthline

Read source
Longevity.Technology3 Jul 2026

Evipedia expands evidence reviews to cover peptides - Longevity.Technology

Evipedia expands evidence reviews to cover peptides Longevity.Technology

Read source
Medical News Today2 Jul 2026

GLP-1s tied to better outcomes for diabetes, peripheral artery disease - Medical News Today

GLP-1s tied to better outcomes for diabetes, peripheral artery disease Medical News Today

Read source
Vascular News2 Jul 2026

GLP-1 medications found to reduce deaths, amputations and hospitalisations in PAD and type 2 diabetes patients - Vascular News

GLP-1 medications found to reduce deaths, amputations and hospitalisations in PAD and type 2 diabetes patients Vascular News

Read source
Woman's World1 Jul 2026

What Is Retatrutide? Dr. Dubrow Calls It the Most Powerful Weight-Loss Drug - Woman's World

What Is Retatrutide? Dr. Dubrow Calls It the Most Powerful Weight-Loss Drug Woman's World

Read source
News-Medical1 Jul 2026

Novel biomimetic peptide actively rebuilds damaged tooth dentin - News-Medical

Novel biomimetic peptide actively rebuilds damaged tooth dentin News-Medical

Read source
News-Medical1 Jul 2026

GLP-1 medications may improve long-term health for people with peripheral artery disease - News-Medical

GLP-1 medications may improve long-term health for people with peripheral artery disease News-Medical

Read source
OCNJ Daily1 Jul 2026

Peptides for Joint Recovery: What Current Studies Suggest - OCNJ Daily

Peptides for Joint Recovery: What Current Studies Suggest OCNJ Daily

Read source
Medical Xpress1 Jul 2026

GLP-1 medications linked to fewer deaths and amputations in people with type 2 diabetes and PAD - Medical Xpress

GLP-1 medications linked to fewer deaths and amputations in people with type 2 diabetes and PAD Medical Xpress

Read source
www.heart.org1 Jul 2026

Can GLP-1 medications improve health in people with Type 2 diabetes and PAD? - www.heart.org

Can GLP-1 medications improve health in people with Type 2 diabetes and PAD? www.heart.org

Read source
NewsNation1 Jul 2026

Women more often hired after losing weight on GLP-1s: Study - NewsNation

Women more often hired after losing weight on GLP-1s: Study NewsNation

Read source
NewsNation28 Jun 2026

New peptide can treat antimicrobial-resistant infections, study finds - NewsNation

New peptide can treat antimicrobial-resistant infections, study finds NewsNation

Read source
Northwestern University24 Jun 2026

New GLP-1 Drug Promotes Weight Loss in Obesity - Northwestern University

New GLP-1 Drug Promotes Weight Loss in Obesity Northwestern University

Read source
University of Alberta23 Jun 2026

Peptide alternative to antibiotics could combat antimicrobial resistance crisis - University of Alberta

Peptide alternative to antibiotics could combat antimicrobial resistance crisis University of Alberta

Read source
Borkena22 Jun 2026

ABP-7 Peptide: A Speculative Exploration of Its Molecular Properties and Expanding Research Horizons - Borkena

ABP-7 Peptide: A Speculative Exploration of Its Molecular Properties and Expanding Research Horizons Borkena

Read source
Nature20 Jun 2026

Food-derived peptide RDP3 mitigates pyroptosis to enhance oral mucosal repair via the IL-2Rβ/PI3K axis - Nature

Food-derived peptide RDP3 mitigates pyroptosis to enhance oral mucosal repair via the IL-2Rβ/PI3K axis Nature

Read source
McGill University18 Jun 2026

Injections of ‘MOTS-c’ Can Make You Live Longer. If You Are a Mouse - McGill University

Injections of ‘MOTS-c’ Can Make You Live Longer. If You Are a Mouse McGill University

Read source
Longevity.Technology17 Jun 2026

Rugiet expands into longevity with peptide therapies - Longevity.Technology

Rugiet expands into longevity with peptide therapies Longevity.Technology

Read source
UCHealth16 Jun 2026

Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery - UCHealth

Retatrutide, the newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery UCHealth

Read source
Nature15 Jun 2026

The latest benefit of obesity drugs: boosting testosterone and sperm quality - Nature

The latest benefit of obesity drugs: boosting testosterone and sperm quality Nature

Read source
News-Medical12 Jun 2026

New peptide strategy may protect brain cells involved in Parkinson's disease - News-Medical

New peptide strategy may protect brain cells involved in Parkinson's disease News-Medical

Read source
WHYY11 Jun 2026

Penn study finds GLP-1 use associated with lower breast cancer risk; researchers to launch clinical trial - WHYY

Penn study finds GLP-1 use associated with lower breast cancer risk; researchers to launch clinical trial WHYY

Read source
The Guardian10 Jun 2026

Weight-loss drug users save more than £400 a year on food as take-up triples - The Guardian

Weight-loss drug users save more than £400 a year on food as take-up triples The Guardian

Read source
NPR9 Jun 2026

GLP-1s appear to protect against cancer. Researchers are trying to figure out how - NPR

GLP-1s appear to protect against cancer. Researchers are trying to figure out how NPR

Read source
The ASCO Post9 Jun 2026

GLP-1 RAs May Reduce Risk of Obesity-Related Cancers - The ASCO Post

GLP-1 RAs May Reduce Risk of Obesity-Related Cancers The ASCO Post

Read source
Phys.org8 Jun 2026

Peptide blocks DNA breaks tied to treatment-induced leukemia, offering new prevention route - Phys.org

Peptide blocks DNA breaks tied to treatment-induced leukemia, offering new prevention route Phys.org

Read source
VCU Health8 Jun 2026

New study reveals turbocharged GLP-1 drug helps shed body weight and fat in the liver - VCU Health

New study reveals turbocharged GLP-1 drug helps shed body weight and fat in the liver VCU Health

Read source
AJMC8 Jun 2026

GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis - AJMC

GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis AJMC

Read source
The Lancet8 Jun 2026

Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial - The Lancet

Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial The Lancet

Read source
Oncology Nursing News6 Jun 2026

GLP-1 Use Linked to 30% Reduced Breast Cancer Risk in Large Cohort Study - Oncology Nursing News

GLP-1 Use Linked to 30% Reduced Breast Cancer Risk in Large Cohort Study Oncology Nursing News

Read source
Medscape4 Jun 2026

Solutions Emerging for Post-GLP-1 Weight Regain - Medscape

Solutions Emerging for Post-GLP-1 Weight Regain Medscape

Read source
UW Medicine | Newsroom2 Jun 2026

Clinical trial studies GLP-1 drug for alcohol-use disorder - UW Medicine | Newsroom

Clinical trial studies GLP-1 drug for alcohol-use disorder UW Medicine | Newsroom

Read source
BMJ Group2 Jun 2026

GLP-1 agonists linked to significantly lower long term risk of knee replacement - BMJ Group

GLP-1 agonists linked to significantly lower long term risk of knee replacement BMJ Group

Read source
UC San Diego Today2 Jun 2026

Study: Popular GLP-1 Drug May Slow Down Biological Aging - UC San Diego Today

Study: Popular GLP-1 Drug May Slow Down Biological Aging UC San Diego Today

Read source
Oncology Nursing News26 May 2026

GLP-1 Receptor Agonists Show Promise in ASCO 2026 Research - Oncology Nursing News

GLP-1 Receptor Agonists Show Promise in ASCO 2026 Research Oncology Nursing News

Read source
St. George News26 May 2026

American Stem Cells and Peptides brings regenerative medicine approach to Southern Utah - St. George News

American Stem Cells and Peptides brings regenerative medicine approach to Southern Utah St. George News

Read source
National Institutes of Health (NIH) | (.gov)22 May 2026

NIH researchers identify avenue for enhanced GLP-1-induced weight loss - National Institutes of Health (NIH) | (.gov)

NIH researchers identify avenue for enhanced GLP-1-induced weight loss National Institutes of Health (NIH) | (.gov)

Read source
Epic Research21 May 2026

GLP-1 Use Has More Than Quadrupled Since 2021 as Obesity Rates Continue to Show Signs of Decline - Epic Research

GLP-1 Use Has More Than Quadrupled Since 2021 as Obesity Rates Continue to Show Signs of Decline Epic Research

Read source
The Independent19 May 2026

GLP-1 weight-loss drugs can do more than shed pounds – here are some of the surprising health benefits - The Independent

GLP-1 weight-loss drugs can do more than shed pounds – here are some of the surprising health benefits The Independent

Read source
Nature13 May 2026

Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discovery - Nature

Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discovery Nature

Read source
WCM Newsroom12 May 2026

Oral GLP-1 Medication Helps Patients Maintain Weight Loss - WCM Newsroom

Oral GLP-1 Medication Helps Patients Maintain Weight Loss WCM Newsroom

Read source
National Institutes of Health (NIH) | (.gov)12 May 2026

GLP-1 plus therapy can reduce heavy drinking - National Institutes of Health (NIH) | (.gov)

GLP-1 plus therapy can reduce heavy drinking National Institutes of Health (NIH) | (.gov)

Read source
Duke School of Medicine12 May 2026

Inside the GLP-1 Revolution - Duke School of Medicine

Inside the GLP-1 Revolution Duke School of Medicine

Read source
Science | AAAS7 May 2026

Building an oral peptide drug - Science | AAAS

Building an oral peptide drug Science | AAAS

Read source
Science | AAAS7 May 2026

Biocatalytic cascades enable manufacture of the macrocyclic peptide enlicitide - Science | AAAS

Biocatalytic cascades enable manufacture of the macrocyclic peptide enlicitide Science | AAAS

Read source
Nature6 May 2026

Expanding the human proteome with microproteins and peptideins - Nature

Expanding the human proteome with microproteins and peptideins Nature

Read source
The Lancet2 May 2026

Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial - The Lancet

Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial The Lancet

Read source
Medical Xpress29 Apr 2026

Preclinical efficacy of experimental peptide therapy suggests a new target for metastatic breast cancer treatments - Medical Xpress

Preclinical efficacy of experimental peptide therapy suggests a new target for metastatic breast cancer treatments Medical Xpress

Read source
Medical Xpress29 Apr 2026

Tumor bacteria inspire peptide that starves prostate cancer cells in preclinical tests - Medical Xpress

Tumor bacteria inspire peptide that starves prostate cancer cells in preclinical tests Medical Xpress

Read source
Trend Hunter28 Apr 2026

Prescription-Dosed Topical Peptide Formulations: Enhanced Spotlights Its GHK-Cu Copper… - Trend Hunter

Prescription-Dosed Topical Peptide Formulations: Enhanced Spotlights Its GHK-Cu Copper… Trend Hunter

Read source
Global Food Industry News21 Apr 2026

GLP-1 uptake “almost doubles” in UK – research - Global Food Industry News

GLP-1 uptake “almost doubles” in UK – research Global Food Industry News

Read source
Arizona Foothills Magazine20 Apr 2026

The Rise of Peptides and Regenerative Aesthetics - Arizona Foothills Magazine

The Rise of Peptides and Regenerative Aesthetics Arizona Foothills Magazine

Read source
Nature17 Apr 2026

Combination of prolonged water fasting and GLP-1 for refractory morbid obesity: Case report - Nature

Combination of prolonged water fasting and GLP-1 for refractory morbid obesity: Case report Nature

Read source
Nature16 Apr 2026

Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats - Nature

Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Nature

Read source
News-Medical13 Apr 2026

Natural peptide PEPITEM shows promise in reducing arthritic joint swelling - News-Medical

Natural peptide PEPITEM shows promise in reducing arthritic joint swelling News-Medical

Read source
Science Partner Journals10 Apr 2026

Mesothelin-Binding Peptide Inhibits Cell Migration and Enables Targeted Delivery of a Mitochondrial-Membrane-Damaging Peptide to Pancreatic Tumors - Science Partner Journals

Mesothelin-Binding Peptide Inhibits Cell Migration and Enables Targeted Delivery of a Mitochondrial-Membrane-Damaging Peptide to Pancreatic Tumors Science Partner Journals

Read source
UW Medicine | Newsroom9 Apr 2026

Evidence, excitement: In the moment with a GLP-1 expert - UW Medicine | Newsroom

Evidence, excitement: In the moment with a GLP-1 expert UW Medicine | Newsroom

Read source
University of Nebraska Medical Center3 Apr 2026

Antimicrobial peptide database is expanded and improved | Newsroom - University of Nebraska Medical Center

Antimicrobial peptide database is expanded and improved | Newsroom University of Nebraska Medical Center

Read source
Wiley & Sons2 Apr 2026

CD28-Targeted Enzyme-Responsive Conformation-Switching Peptide Self-Assembly for Selective T-Cell Acute Lymphoblastic Leukemia (T-ALL) Therapy - Wiley & Sons

CD28-Targeted Enzyme-Responsive Conformation-Switching Peptide Self-Assembly for Selective T-Cell Acute Lymphoblastic Leukemia (T-ALL) Therapy Wiley & Sons

Read source
NDTV1 Apr 2026

Once-Restricted Peptides May Make A Return: What This Means For Skin Care - NDTV

Once-Restricted Peptides May Make A Return: What This Means For Skin Care NDTV

Read source
Aidsmap27 Mar 2026

GLP-1 agonists could be a global game-changer, but need to be accessible and affordable - Aidsmap

GLP-1 agonists could be a global game-changer, but need to be accessible and affordable Aidsmap

Read source
Telangana Today27 Mar 2026

The Rise of Peptide Therapy in India: Dr. Harikiran Chekuri Leads the Shift Toward Longevity Medicine - Telangana Today

The Rise of Peptide Therapy in India: Dr. Harikiran Chekuri Leads the Shift Toward Longevity Medicine Telangana Today

Read source
Drug Target Review26 Mar 2026

AI discovers peptide that eases ulcerative colitis symptoms - Drug Target Review

AI discovers peptide that eases ulcerative colitis symptoms Drug Target Review

Read source
Cleveland Clinic26 Mar 2026

New Analysis Examines Long-Term Outcomes of GLP-1 Therapies in Type 1 Diabetes - Cleveland Clinic

New Analysis Examines Long-Term Outcomes of GLP-1 Therapies in Type 1 Diabetes Cleveland Clinic

Read source
Johns Hopkins Bloomberg School of Public Health24 Mar 2026

Improved Heart and Kidney Outcomes for Type 1 Diabetes Patients Taking GLP-1 Weight Loss Drugs - Johns Hopkins Bloomberg School of Public Health

Improved Heart and Kidney Outcomes for Type 1 Diabetes Patients Taking GLP-1 Weight Loss Drugs Johns Hopkins Bloomberg School of Public Health

Read source